China, January 10, 2024 — GATE Press, an innovative academic publisher dedicated to disseminating leading research, launched today. The new publishing house aims to accelerate scientific discovery by connecting researchers across disciplines and borders.

“GATE Press aspires to open new gateways to knowledge creation and sharing among scholars worldwide,” said Dr. Liu, CEO of GATE Press. “We are building a collaborative global platform to publish groundbreaking research in all scientific fields.”

The company’s first journal,Neuropharmacology and Therapy, will focus on regiments and mechanisms of new drugs and neurosurgical therapies of various dysfunctions in the nervous system. GATE Press has assembled an editorial board of prominent neuroscientists to ensure the highest quality standards.

“We could not have a stronger foundation to launch GATE Press than with Neuropharmacology and Therapy,” Dr. Liu remarked. “Our exceptional editors and reviewers give us great optimism that Neuropharmacology and Therapy will publish work that profoundly advances understanding of the treatment therapies of brain disorders.”

GATE Press aims to shake up academic publishing traditions by promoting open science and accelerated researcher-to-researcher communications. The publisher will utilize cutting-edge technology to facilitate cross-disciplinary idea exchange through interactive forums paired with its journals.

“If we foster better global collaboration in the work we publish, human knowledge will grow much faster” said Dr. Liu. “That is the driving ethos behind GATE Press.”